Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general …
…, O Elalouf, I Kaufman, R Meidan, A Broyde… - Annals of the …, 2021 - ard.bmj.com
Introduction Vaccination represents a cornerstone in mastering the COVID-19 pandemic.
Data on immunogenicity and safety of messenger RNA (mRNA) vaccines in patients with …
Data on immunogenicity and safety of messenger RNA (mRNA) vaccines in patients with …
Role and prognostic significance of the Ki‐67 index in non‐Hodgkin's lymphoma
A Broyde, O Boycov, Y Strenov, E Okon… - American journal of …, 2009 - Wiley Online Library
Expression of Ki‐67, a nuclear antigen protein present in all cycling cells, is used to determine
the growth fraction of tumors. The aim of this study was to evaluate the role and prognostic …
the growth fraction of tumors. The aim of this study was to evaluate the role and prognostic …
[HTML][HTML] The effect of tocilizumab on inflammatory markers in patients hospitalized with serious infections. Case series and review of literature
…, R Ben-Ami, S Berliner, M Anouk, I Kaufman, A Broyde… - Life, 2021 - mdpi.com
Background: The human anti-IL-6 receptor antibody tocilizumab (TCZ) has been approved
for the treatment of rheumatoid arthritis (RA) and giant cell arteritis (GCA). It is observed that …
for the treatment of rheumatoid arthritis (RA) and giant cell arteritis (GCA). It is observed that …
[HTML][HTML] Predictors of immunogenic response to the BNT162b2 mRNA COVID-19 vaccination in patients with autoimmune inflammatory rheumatic diseases treated …
…, M Zisapel, O Elalouf, I Kaufman, A Broyde… - Vaccines, 2022 - mdpi.com
Treatment with rituximab (RTX) blunts SARS-CoV-2 vaccination-induced humoral response.
We sought to identify predictors of a positive immunogenic response to the BNT162b2 …
We sought to identify predictors of a positive immunogenic response to the BNT162b2 …
Immunogenicity induced by two and three doses of the BNT162b2 mRNA vaccine in patients with autoimmune inflammatory rheumatic diseases and …
…, D Levartovsky, I Kaufman, A Broyde… - Annals of the …, 2022 - ard.bmj.com
Objectives To evaluate long-term kinetics of the BNT162b2 mRNA vaccine-induced immune
response in adult patients with autoimmune inflammatory rheumatic diseases (AIIRD) and …
response in adult patients with autoimmune inflammatory rheumatic diseases (AIIRD) and …
Longterm efficacy of an antipneumococcal polysaccharide vaccine among patients with autoimmune inflammatory rheumatic diseases
A Broyde, U Arad, N Madar-Balakirski… - The Journal of …, 2016 - jrheum.org
Objective. To estimate the longterm humoral response of an antipneumococcal polysaccharide
vaccine (PPSV23) in patients with rheumatoid arthritis (RA), psoriatic arthritis (PsA), …
vaccine (PPSV23) in patients with rheumatoid arthritis (RA), psoriatic arthritis (PsA), …
Role of ultrasound for assessment of psoriatic arthritis patients with fibromyalgia
…, H Sarbagil-Maman, S Borok, A Broyde… - Annals of the …, 2021 - ard.bmj.com
Objective To investigate whether ultrasonography (US), as an objective imaging modality,
can optimise the evaluation of disease activity in psoriatic arthritis (PsA) patients with …
can optimise the evaluation of disease activity in psoriatic arthritis (PsA) patients with …
Effect of secukinumab and tumor necrosis factor inhibitors on humoral response to BNT162b2 mRNA vaccine in patients with spondyloarthritis compared to …
…, D Levartovsky, I Kaufman, A Broyde… - The Journal of …, 2024 - jrheum.org
Objective To assess the humoral response to the BNT162b2 mRNA vaccine among patients
with spondyloarthritis (SpA) receiving secukinumab (SEC) compared to those receiving …
with spondyloarthritis (SpA) receiving secukinumab (SEC) compared to those receiving …
Secukinumab and TNF-α inhibitors' effect on the humoral response to BNT162b2 mRNA vaccine in spondyloarthritis patients compared to immunocompetent controls
…, D Levartovsky, I Kaufman, A Broyde… - The Journal of …, 2023 - jrheum.org
Objective To assess the humoral response to the BNT162b2 mRNA vaccine among patients
with spondyloarthritis (SpA) receiving secukinumab (SEC) compared to those receiving …
with spondyloarthritis (SpA) receiving secukinumab (SEC) compared to those receiving …
[HTML][HTML] Idiopathic Eosinophilic Vasculitis: Case Presentation and Literature Review
A Broyde, O Elkayam - Rambam Maimonides Medical Journal, 2023 - ncbi.nlm.nih.gov
Objective Idiopathic eosinophilic vasculitis has been described in previous case series as a
possible manifestation of hypereosinophilic syndrome (HES) in asthma-free patients. A rare …
possible manifestation of hypereosinophilic syndrome (HES) in asthma-free patients. A rare …